BTN2A1 and neoplasm: For instance, it has been reported a bispecific γδ T cell engager (GADLEN), containing heterodimeric BTN2A1 and BTN3A1 extracellular domains (ECD) fused via inert Fc linkers to scFv domain targeting a tumor-antigen (CD19 or CD20) (60).